Using methylation signatures on cell-free DNA for early cancer detection: a new era in liquid biopsy?

Ann Oncol. 2020 Jun;31(6):665-667. doi: 10.1016/j.annonc.2020.03.307. Epub 2020 Apr 11.

Authors

C Bailleux¹, L Lacroix², E Barranger³, S Delaloge⁴

Affiliations

¹ Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
² Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France.
³ Department of Surgery, Centre Antoine Lacassagne, Nice, France.
⁴ Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Inserm U931, Cancer Biomarkers, Université Paris Saclay, Gustave Roussy, Villejuif, France. Electronic address: [email protected].

PMID: 32289381
DOI: 10.1016/j.annonc.2020.03.307

No abstract available

Publication types

Editorial

MeSH terms

Biomarkers, Tumor / analysis
Cell-Free Nucleic Acids*
DNA Methylation
Early Detection of Cancer
Humans
Liquid Biopsy
Methylation
Neoplasms* / diagnosis
Neoplasms* / genetics

Substances

Biomarkers, Tumor
Cell-Free Nucleic Acids